DrugPatentWatch Database Preview
Adapt Company Profile
What is the competitive landscape for ADAPT, and what generic alternatives to ADAPT drugs are available?
ADAPT has two approved drugs.
There are eight US patents protecting ADAPT drugs.
Summary for Adapt
| US Patents: | 8 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 2 |
Drugs and US Patents for Adapt
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adapt | NARCAN | naloxone hydrochloride | SPRAY, METERED;NASAL | 208411-002 | Jan 24, 2017 | DISCN | Yes | No | 9,707,226 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Adapt | NARCAN | naloxone hydrochloride | INJECTABLE;INJECTION | 016636-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Adapt | NARCAN | naloxone hydrochloride | SPRAY, METERED;NASAL | 208411-001 | Nov 18, 2015 | RX | Yes | Yes | 9,468,747 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Adapt | NARCAN | naloxone hydrochloride | SPRAY, METERED;NASAL | 208411-001 | Nov 18, 2015 | RX | Yes | Yes | 10,085,937 | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Paragraph IV (Patent) Challenges for ADAPT drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Nasal Spray | 4 mg/spray | ➤ Subscribe | 2016-07-15 |
International Patents for Adapt Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Canada | 2950687 | ➤ Try a Free Trial |
| World Intellectual Property Organization (WIPO) | 2017049181 | ➤ Try a Free Trial |
| Singapore | 11201607281P | ➤ Try a Free Trial |
| Canada | 2942611 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Adapt Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 292 | Luxembourg | ➤ Try a Free Trial | PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
